The role of litigation in defining drug risks.
Kesselheim
Aaron S
AS
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA. akesselheim@partners.org
Avorn
Jerry
J
D016907:Adverse Drug Reaction Reporting Systems; D064420:Drug-Related Side Effects and Adverse Reactions; D006291:Health Policy; D006801:Humans; D007880:Legislation, Drug; D016365:Liability, Legal; D014481:United States; D014486:United States Food and Drug Administration